Elite Pharmaceuticals Stock Drops Below 200-Day Average

Shares of the specialty pharmaceutical company hit a new low as it continues to face market challenges.

Feb. 7, 2026 at 5:55pm

Got story updates? Submit your updates here. ›

Elite Pharmaceuticals Inc. (OTCMKTS:ELTP), a specialty pharmaceutical company focused on complex drug formulations, saw its stock price fall below its 200-day moving average during trading on Thursday. The stock traded as low as $0.3707 before closing at $0.3762 on volume of 1.6 million shares.

Why it matters

Elite Pharmaceuticals' stock performance is an indicator of the company's overall financial health and market position. Falling below the 200-day moving average, a key technical indicator, suggests the stock may face continued downward pressure and challenges in the near term.

The details

Elite Pharmaceuticals, headquartered in Houston, Texas, is a specialty pharmaceutical company that develops and markets branded and generic drugs, with a focus on complex formulations like injectables and oncology therapies. The company has a debt-to-equity ratio of 0.06 and current and quick ratios of 8.04 and 6.34 respectively, indicating a strong financial position. However, the stock's 50-day and 200-day simple moving averages have been declining, reflecting broader market concerns.

  • Elite Pharmaceuticals' stock price fell below its 200-day moving average of $0.56 during trading on Thursday, February 7, 2026.

The players

Elite Pharmaceuticals, Inc.

A U.S.-based specialty pharmaceutical company that acquires, develops and markets both branded and generic pharmaceutical products, with a focus on complex dosage forms such as injectables, sterile formulations and oncology therapies.

Got photos? Submit your photos here. ›

The takeaway

Elite Pharmaceuticals' stock price falling below its 200-day moving average suggests the company may be facing headwinds in the market, despite its strong financial position. Investors will be closely watching to see if the stock can regain its footing and return above this key technical indicator.